RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL/LAL+, collectively the "LAL"), RxSight Light Delivery Device (LDD) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at .ALISO VIEJO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference.
加州阿利索维耶霍，2025年1月2日（环球新闻）--（纳斯达克：RXST）– RxSight公司是一家致力于为白内障手术后患者提供高质量定制视力的眼科器械公司，今天宣布计划参加即将举行的J.P.摩根医疗会议。
RxSight's management is scheduled to present on Wednesday, January 15, 2025, at 9:45 a.m. Pacific Time / 12:45 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: .
RxSight的管理层定于2025年1月15日星期三，太平洋时间上午9:45 / 东部时间下午12:45进行演讲。有关方可以通过以下链接访问演讲的直播和回放网络广播：.
About RxSight, Inc.
关于RxSight公司。
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL/LAL+, collectively the "LAL"), RxSight Light Delivery Device (LDD) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at .
RxSight公司是一家致力于为白内障手术后患者提供高质量定制视力的眼科器械公司。RxSight可调光透镜系统，由RxSight可调光透镜（LAL/LAL+，统称为"LAL"）、RxSight光源装置（LDD）及配件组成，是首个也是唯一可商用的术后可调眼内透镜（IOL）技术，使医生能够在白内障手术后定制并提供高质量视力。有关RxSight的更多信息，请访问.
Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com
公司联系:
谢莉·B·桑农
首席财务官
sthunen@rxsight.com
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
投资者关系联系：
奥利弗·莫拉夫采维奇
投资者关系副总裁
omoravcevic@rxsight.com